Keyword Analysis & Research: risedronate and renal function

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
risedronate and renal function	1.48	0.3	3859	25	30
risedronate	1.64	0.3	1314	81	11
and	0.83	0.4	4383	67	3
renal	0.1	0.7	5565	100	5
function	0.1	0.1	189	34	8

Keyword	CPC	PCC	Volume	Score
risedronate and renal function	0.96	1	9382	15
risedronate renal function	1.15	0.4	7698	8
risedronate mechanism of action	1.44	0.8	3738	77
risedronate patient information leaflet	0.34	0.2	4860	29
risedronate is indicated for	0.41	0.6	9056	57
what kind of medication is risedronate	0.22	0.7	8809	82
how does risedronate work	1.22	0.3	2165	96
what is risedronate prescribed for	0.32	0.4	8291	43
risedronate and dental work	0.88	1	3540	89
risedronate sodium patients reviews	1.47	0.9	4049	56
risedronate para que sirve	1.23	0.8	3430	2
risedronate sodium used for	1.68	0.2	2387	47
risedronate and bladder infection	1.38	1	2696	28
how does risedronate sodium work	0.25	0.8	2017	30
risedronate mode of action	1.45	0.6	8898	34
risedronate sodium drug class	1.08	0.6	5778	74
risedronate potential side effect	0.27	0.3	7468	30
what is risedronate sodium used to treat	1.88	0.1	9489	8
risedronate 35 mg effets secondaires	1.57	0.2	1730	59
what kind of medication is risedronate sodium	1.36	0.3	518	55
what are the side effects of risedronate	1.73	0.3	2185	3

Bisphosphonate Nephrotoxicity Risks and Use in CKD Patients
uspharmacist.com

https://www.uspharmacist.com/article/bisphosphonate-nephrotoxicity-risks-and-use-in-ckd-patients

DA: 74 PA: 77 MOZ Rank: 87

Safety and efficacy of risedronate in patients with age
nih.gov

https://pubmed.ncbi.nlm.nih.gov/16294264/

DA: 4 PA: 60 MOZ Rank: 11

Bisphosphonates for Osteoporosis in Patients with …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777575/table/t4-cjhp-69-14/

WEBSafety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005; 20 (12):2105–15. doi: 10.1359/JBMR.050817.

DA: 13 PA: 15 MOZ Rank: 41

Risedronate therapy in patients with mild-to-moderate chronic …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/16813531/

WEBThere was also no exacerbation of impaired kidney function associated with risedronate administration in the subjects with eGFR above 30 mL/min/1.73 m 2. Risedronate …

DA: 78 PA: 66 MOZ Rank: 16

Management of Osteoporosis in Chronic Kidney Disease - PMC
ajkd.org

https://www.ajkd.org/article/S0272-6386(21)00797-6/fulltext

WEBSafety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J …

DA: 70 PA: 91 MOZ Rank: 70